Availability and Prescribing Status in the UK Neither compound is routinely available in the UK: tesamorelin requires named-patient importation as an unlicensed medicine, and retatrutide is only accessible through regulated clinical trials
This unique mechanism amplifies metabolic benefits, leading to superior glycemic control, significant weight reduction, and cardiovascular protection
Less common but more serious risks include: Pancreatitis, which can cause severe abdominal pain and may require stopping the medication Gallbladder problems, such as gallstones or inflammation, especially with higher doses or longer use Allergic reactions, including swelling or difficulty breathing, which need immediate medical attention Injection site reactions, such as redness or itching, with injectable forms Rare vision changes or worsening diabetic eye disease, especially when blood sugar improves rapidly Anyone with intense abdominal pain, signs of dehydration (such as dizziness or reduced urination), or unexpected vision changes should seek medical advice promptly
The magnitude of effect is different
To get a 1mg/ml concentration, you would add 10ml of bac water to your 10mg vial of retatrutide
Freezing a reconstituted peptide solution causes ice crystals to form within the liquid
